Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study (vol 40, pg 2077, 2018)

Kresa-Reahl Kiren; Repovic Pavle; Robertson Derrick; Okwuokenye Macaulay; Meltzer Leslie; Mendoza Jason P.

首页> 外文期刊>Clinical therapeutics >Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study (vol 40, pg 2077, 2018)

【24h】

Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study (vol 40, pg 2077, 2018)

机译：富马酸乳酸延迟释放二甲基患者患者临床和患者报告的结果的有效性，从Glatiramer醋酸酯复发多发性硬化切换：响应，前瞻性观察研究（Vol 40，PG 2077,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical therapeutics》 |2019年第12期|共1页
作者
Kresa-Reahl Kiren; Repovic Pavle; Robertson Derrick; Okwuokenye Macaulay; Meltzer Leslie; Mendoza Jason P.;
展开▼
作者单位

Providence Multiple Sclerosis Ctr Portland OR USA;

Swedish Neurosci Inst Multiple Sclerosis Ctr Seattle WA USA;

USF Multiple Sclerosis Ctr Tampa FL USA;

Biogen Cambridge MA 02142 USA;

Biogen Cambridge MA 02142 USA;

Biogen Cambridge MA 02142 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study (vol 40, pg 2077, 2018) [J] . Kresa-Reahl Kiren, Repovic Pavle, Robertson Derrick, Clinical therapeutics . 2019,第12期

机译：富马酸乳酸延迟释放二甲基患者患者临床和患者报告的结果的有效性，从Glatiramer醋酸酯复发多发性硬化切换：响应，前瞻性观察研究（Vol 40，PG 2077,2018）
2. Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study [J] . Kresa-Reahl Kiren, Repovic Pavle, Robertson Derrick, Clinical therapeutics . 2018,第12期

机译：促进释放二甲基富马酸乳酸型患者患者临床和患者报告结果的有效性，从Glativeramer醋酸酯复发多发性硬化切换：响应，前瞻性观察研究
3. Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC [J] . T Berger, B Brochet, L Brambilla, Multiple Sclerosis Journal ?C Experimental, Translational and Clinical . 2019,第4期

机译：在现实世界临床环境中复发延迟患者患者报告的患者报告结果和临床措施的有效性：PROTEC
4. The Impact of Peri-implant Soft Tissue Properties on Patient-reported and Clinically Assessed Outcomes: A Prospective Study. [D] . Bonino, Francesca. 2015

机译：植入物周围软组织特性对患者报告和临床评估结果的影响：一项前瞻性研究。
5. Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis [O] . Jonathan Calkwood, Timothy Vollmer, Robert J. Fox, 2016

机译：延缓释放富马酸二甲酯与干扰素β或醋酸格拉替雷在复发性多发性硬化症中的安全性和耐受性
6. Corrigendum to “Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study” Clinical Therapeutics 40 (12) (2018) 2077–2087 [O] . Kiren Kresa-Reahl, Pavle Repovic, Derrick Robertson, 2019

机译：“延迟释放二甲基富马酸二甲基患者患者临床和患者报告的患者的临床和患者报告结果的勘探性勘察：响应，一个前瞻性观察研究”临床治疗40（12）（2018）2077-2087

Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study (vol 40, pg 2077, 2018)

著录项

相似文献

相关主题

期刊订阅